Chaperone ligand-discrimination by the TPR-domain protein Tah1 by Millson, Stefan H. et al.
Biochem. J. (2008) 413, 261–268 (Printed in Great Britain) doi:10.1042/BJ20080105 261
Chaperone ligand-discrimination by the TPR-domain protein Tah1
Stefan H. MILLSON*, Cara K. VAUGHAN†, Chao ZHAI‡, Maruf M. U. ALI†, Barry PANARETOU‡, Peter W. PIPER*,
Laurence H. PEARL† and Chrisostomos PRODROMOU†1
*Department of Molecular Biology and Biotechnology, The University of Shefﬁeld, Firth Court, Western Bank, Shefﬁeld S10 2TN, U.K., †Section of Structural Biology, The Institute of
Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, U.K., and ‡Pharmaceutical Science Research Division, King’s College London, Franklin-Wilkins
Building, 150 Stamford Street, London SE1 9NH, U.K.
Tah1 [TPR (tetratricopeptide repeat)-containing protein associ-
ated with Hsp (heat-shock protein) 90] has been identiﬁed as
a TPR-domain protein. TPR-domain proteins are involved in
protein–protein interactions and a number have been character-
ized that interact either with Hsp70 or Hsp90, but a few can bind
both chaperones. Independent studies suggest that Tah1 interacts
with Hsp90, but whether it can also interact with Hsp70/Ssa1
has not been investigated. Amino-acid-sequence alignments sug-
gest that Tah1 is most similar to the TPR2b domain of Hop
(Hsp-organizing protein) which when mutated reduces binding
to both Hsp90 and Hsp70. Our alignments suggest that there are
three TPR-domain motifs in Tah1, which is consistent with the
architecture of the TPR2b domain. In the present study we ﬁnd
thatTah1isspeciﬁcforHsp90,andisabletobindtightlytheyeast
Hsp90, and the human Hsp90α and Hsp90β proteins, but not the
yeast Hsp70 Ssa1 isoform. Tah1 acheives ligand discrimination
by favourably binding the methionine residue in the conserved
MEEVD motif (Hsp90) and positively discriminating against the
ﬁrst valine residue in the VEEVD motif (Ssa1). In the present
study we also show that Tah1 can affect the ATPase activity of
Hsp90, in common with some other TPR-domain proteins.
Key words: ATPase activity, heat-shock protein 90 (Hsp90),
heat-shock protein 70 (Hsp70), tetratricopeptide-repeat-contain-
ing protein associated with heat-shock protein 90 (Tah1),
tetratricopeptide repeat (TPR) domain, stress-inducible protein
1/heat-shock protein organizing protein/p60 (Sti1/Hop/p60).
INTRODUCTION
The molecular chaperone Hsp (heat-shock protein) 90 plays a
central role in the maturation and activation of key signalling
proteins(reviewedin[1,2])thatincludesteroidhormonereceptors
[3,4] and protein kinases [5–9] among others [1,2,10,11]. An up-
to-date comprehensive list can be found at http://www.picard.ch/
downloads/downloads.htm.Theactivationofsuchproteins(client
proteins) is regulated by the association of speciﬁc co-chaper-
ones that complex with Hsp90 at various stages of the chaperone
cycle [12,13]. A number of these co-chaperones play an apparent
role in recruiting client proteins to the Hsp90 chaperone
complex. For steroid hormone receptors it appears that the
receptor is complexed with the TPR (teratricopeptide repeat)-
domain containing co-chaperone Hop (Hsp-organizing protein)/
Sti1 (stress-inducible protein 1; the yeast homologue of Hop)
and Hsp70. Binding of Hop/Sti1 to the conserved MEEVD motif
at the extreme C-terminal end of Hsp90 delivers the steroid
hormone receptor to Hsp90 (reviewed in [4,14]). Protein kinases
on the other hand are complexed with Cdc37 (cell-division
cycle 37 homologue)/p50 (reviewed in [15]) that binds the N-
terminaldomainofHsp90[16].InSacharomycescerevisiae,T ah1
(TPR-containing protein associated with Hsp90; YCR060W),
consistingof111aminoacidresidues,wasidentiﬁedasanHsp90-
interacting co-chaperone in three independent studies [17–19].
Tah1 is thought to associate with Pih1 (protein interacting with
Hsp90) and together complex with the essential DNA helicases,
Rvb (RuVB-like)1 and Rvb2, that are key components of the
chromatin remodelling complexes Ino80 and SWR-C [19]. Tah1
contains a single TPR domain with at least two TPR motifs [19].
Numerous crystallographic structures of TPR-domain-contain-
ing proteins have been solved [20–25]. These reveal a common
motif that is composed of a degenerate 34-amino-acid sequence
that forms an antiparallel α-helical hairpin, which in turn cluster
to form a domain with a grooved surface that acts as a peptide-
binding site. TPR domains mediate protein–protein interactions
in numerous protein complexes [26–28]. The question of ligand
discrimination by TPR domains has been addressed [29–31].
TPR-domain proteins such as Hip (Hsp-interacting protein) have
been implicated in the regulation of the ATPase activity of
Hsp70, whereas Hop/Sti1 has been shown to inhibit the ATPase
activity of Hsp90, to activate Ssa1, but to have no affect on the
vertebrateHsp70[32–36].TheTPRdomainsofHsp70andHsp90
co-chaperones interact with the extreme C-terminal amino acid
sequences of their respective chaperone [34,37–41], which share
a common motif (EEVD). Residues immediately upstream of
the conserved EEVD motif of Hsp70 and Hsp90 achieve select-
ive binding to different TPR-domains [20–23,25]. In contrast, the
co-chaperone CHIP (C-terminal of Hsp70-interacting protein),
involved in the ubiquitylation of chaperone-bound client proteins
[42,43], binds to both Hsp70 and Hsp90 by associating with
the MEEVD (Hsp90) or the IEEVD (human Hsp70) motif and
avoiding further interaction with upstream amino acid residues.
This is achieved by a hydrophobic pocket that accommodates
the methionine residue (M in MEEVD) from Hsp90 and the
isoleucine residue (I in IEEVD) of human Hsp70 and in doing
Abbreviations used: CHIP, C-terminal of heat-shock protein 70-interacting protein; Cpr6, cyclosporin-sensitive proline rotamase 6; FKBP51, FK506-
binding protein 51; GST, glutathione transferase; Hop, heat-shock-protein-organizing protein; Hsp, heat-shock protein; ITC, isothermal titration calorimetry;
Sti1, stress-inducible protein 1 (the yeast homologue of Hop); cSti1, C-terminal of Sti1; Tah1, tetratricopeptide-repeat-containing protein associated with
Hsp90; TPR, tetratricopeptide repeat.
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so twists the upstream peptide, which differs between the two
chaperones, and hoists it clear of the TPR-domain groove [24]. In
contrast, structural information showed that for Hop/Sti1 the N-
terminal TPR domain (TPR1) interacts with Hsp70, whereas the
central TPR domain (TPR2a) binds to Hsp90 [21]. However,
the situation might be more complex in that mutations in the
third TPR domain (TPR2b) disrupt association with both Hsp70
and Hsp90 [39]. A high-afﬁnity ligand for the TPR2b domain has
not been found [21,29].
InthepresentstudyweshowthattheTPRdomainofTah1most
closely resembles the TPR2b domain of Hop/Sti1 and address
whetherTah1isanHsp90-speciﬁcco-chaperoneorwhetheritcan
alsoassociatespeciﬁcallywithSsa1.WeshowthatTah1isspeciﬁc
forHsp90andthatliganddiscriminationisachievedbyfavourable
bindingofthemethionineresidueoftheconservedMEEVDmotif
of Hsp90 and by positively discriminating against the ﬁrst valine
residue of the VEEVD motif of Ssa1. We also characterize the
oligomeric state of Tah1 and investigate its ability to regulate
the ATPase activity of Hsp90.
MATERIALS AND METHODS
Sequence alignments
The amino acid sequences for Tah1, Sti1 and Hop were obtained
from GenBank®. The accession numbers were: human Hop,
NM_006819; S. cerevisiae Sti1, Z74935; and S. cerevisiae
Tah1, NC_001135. The sequence alignment was generated using
ClustalW [44] on-line at the EMBL-EBI (European Molecular
Biology Laboratory-European Bioinformatic Institute).
Protein production and Hsp90 ATPase activity assays
Expression and puriﬁcation of wild-type and mutant forms
of His-tagged yeast Hsp90, His-tagged Hsp90β,m o u s eH i s -
PreScission-tagged CHIP and His-tagged C-terminal domain of
Sti1 (cSti1) have been described previously [24,35,45]. The yeast
Tah1, the human Hsp90α and the C-terminal domain of
yeast Hsp90 were cloned into pRSETA as NheI-EcoRI, NheI-PstI
and NheI-HindIII DNA fragments respectively, and expressed as
His-PreScission-tagged proteins. The yeast Ssa1 gene was cloned
into pRSETA as an NheI-HindIII DNA fragment and expressed
as a His-tagged fusion protein. The same protein puriﬁcation
procedure as was used for yeast Hsp90 was employed to purify
the C-terminal domain of Hsp90, Hsp90α, Ssa1 and Tah1.
PreScission cleavage of the His tags was carried out overnight at
4◦C, following the manufacturer’s protocol (GE Healthcare). The
cleaved sample was then passed through a 1 ml GST (glutathione
transferase)-HiTrap column, equilibrated in 20 mM Tris/HCl
(pH 7.5), 140 mM NaCl and 2.7 mM KCl, to remove GST-tagged
PreScission. The ﬂow-through was collected, desalted and then
subjected to Talon-afﬁnity chromatography to remove uncleaved
His-PreScission protein. The Talon resin ﬂow-through was then
concentrated and subjected to Superdex 75- or 200-HR gel-
ﬁltration chromatography, as appropriate. All puriﬁed proteins
were dialysed against20 mM Tris/HCl (pH 7.5)containing 1 mM
EDTAand1 mMDTT(dithiothreitol)andthenconcentratedusing
Vivaspin concentrators (Sartorius) with an appropriate molecular
mass cut-off. The ATPase assays were performed in triplicate as
previously described [45,46], using 2 μM yeast Hsp90 and either
20 μMT a h 1o r3 0μM geldanamycin. The protein concentration
was determined by using the molar absorption coefﬁcient (ε)o f
theprotein(wild-typeandmutantyeastHsp90,54050 M
−1 ·cm
−1;
cleaved C-terminal domain of yeast Hsp90, 18260 M
−1 ·cm
−1;
cleaved Hsp90α, 59625 M
−1 ·cm
−1; Hsp90β, 58135 M
−1 ·cm
−1;
Ssa1, 20045 M
−1 ·cm
−1; cleaved CHIP, 29380 M
−1 ·cm
−1; cSti1,
34480 M
−1 ·cm
−1; and cleaved Tah1, 10295 M
−1 ·cm
−1).
ITC (isothermal titration calorimetry): stoichiometry and Kd
determination.
TheheatofinteractionwasmeasuredonaMSCsystem(Microcal)
with a cell volume of 1.458 ml. For Tah1 and CHIP interactions,
9–11 aliquots of 27 μl of 300 μM Tah1 or CHIP were injected
into 30 μM yeast Hsp90, yeast Hsp90 M705V, human Hsp90α,
human Hsp90β or yeast Hsp90 C-terminal domain at 4◦C( T a h 1
experiments) or 30◦C (CHIP experiments) in 20 mM Tris/HCl
(pH 8.0) containing 1 mM EDTA and 5 mM NaCl. For peptide
interactions, either 9–11 aliquots of 27 μl of 300 μMp e p t i d eo r
14–15 aliquots of 400 μM peptide were injected into 30 μM
Tah1 at 4 ◦Cin 20 mM Tris/HCl (pH 8.0)containing 1 mM EDTA
and 5 mM NaCl. For cSti1 interactions, 11 aliquots of 27 μlo f
300 μM cSti1 were injected into 30 μM yeast Hsp90 or yeast
Hsp90 M705V at 30◦C in 20 mM Tris/HCl (pH 8.0) containing
1 mM EDTA and 5 mM NaCl. The heat of dilution was deter-
mined in a separate experiment by diluting protein or peptide
into buffer, and the corrected data were ﬁtted using a non-linear
least square curve-ﬁtting algorithm (Microcal Origin) with three
ﬂoating variables: stoichiometry, binding constant and change
in enthalpy of interaction. For the Ssa1-Tah1 and Tah1-VEEVD
peptide experiment the stoichiometry was ﬁxed at N=1. All pep-
tides were accurately weighed on an analytical balance and
dissolved in dialysis buffer.
Relative molecular mass determination by gel ﬁltration
Aliquots of 0.5 ml of PreScission-cleaved Tah1 (1.4 mg·ml
−1)
were loaded on to a Superdex 75 HR 16/60 column equilibrated
in 20 mM Tris/HCl (pH 7.4), 1 mM EDTA and 250 mM NaCl.
The column was run at 0.5 ml·min
−1 and was calibrated using
gel-ﬁltration standards from Bio-Rad (bovine thyroglobulin, Mr
670000; bovine γ-globulin, Mr 158000; chicken ovalbumin,
Mr 44000; horse myoglobin, Mr 17000; and vitamin B12, Mr
1350) and GE Healthcare (blue dextran 2000, Mr 2000000;
bovinealbumin,Mr 67500;chickenovalbumin,Mr 43000;bovine
chymotrypsinogen A, Mr 25700 and bovine ribonuclease A, Mr
13700). The relative molecular mass of Tah1 was determined by
logarithmic interpolation.
Analytical ultracentrifugation
PreScission-cleaved Tah1 was dialysed against 20 mM Tris/HCl
(pH 7.5)containing1 mMEDTAand5 mMNaCl.Sedimentation
equilibrium analysis was performed at 20◦C in a Beckman
XL-I analytical ultracentrifuge, following a standard operating
procedure SE_IO_07.1 at sample concentrations of 7.0 and
0.5 mg·ml
−1 (547 and 39 μM respectively). After initial scans
at 726 g to check for the presence of any large aggregates, a ﬁnal
rotor speed of 39030 g was selected. A 12 mm optical path length
centrepiece was used in the cell. Scans were taken every 60 min
and data were logged to disk using the Beckman software. After
24 h, no further change could be detected in the scans, and the run
was terminated. The data were analysed by three methods using
the INVEQ , the recently derived Mﬁt and a local (OS-X-proﬁt)
version of the widely used NONLIN algorithm. Ka values were
converted into Kd values by simple reciprocation.
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Figure 1 ITC of Tah1 with Hsp90 and Ssa1
I T Cb yi n j e c t i n gT a h 1i n t o( a) yeast Hsp90 (yHsp90), (b) the C-terminal domain of yeast Hsp90
(C-yHsp90), (c) Hsp90α,( d) Hsp90β and (e) Ssa1. The results show that the Tah1 interaction
with full-length yeast Hsp90, Hsp90α, Hsp90β and C-yHsp90 is signiﬁcantly tighter than
against the yeast Hsp70, Ssa1.
RESULTS
Tah1 selectively binds Hsp90
Tah1 has been identiﬁed as a TPR-domain protein that interacts
with Hsp90. Our sequence alignments suggest that Tah1 is most
similar to the TPR2b-domain of Hop/Sti1 (Supplementary Fig-
ure S1 at http://www.BiochemJ.org/bj/413/bj4130261add.htm),
which inﬂuences the binding of Hop to both Hsp70 and Hsp90
[39]. In order to investigate the ability of Tah1 to bind both
Ssa1 and Hsp90 we used ITC to determine the extent of any
interaction. Figure 1(a) shows that Tah1 binds to the full-length
yeast Hsp90 (Kd =0.78+ −0.06 μM) with a stoichiometry of 1:1,
whereas Figure 1(b) shows that the binding site is solely located
in the C-terminal domain of Hsp90 (Kd =0.32+ −0.03 μM).
Table 1 summarizes all ITC data in the present study. Tah1
was also shown to be able to interact with the human Hsp90α
(Kd =0.33+ −0.03 μM) and Hsp90β (Kd =0.34+ −0.07 μM)
paralogues with a similar afﬁnity (Figures 1c and 1d). However,
its interaction with the yeast Ssa1 was signiﬁcantly weaker (Kd =
16+ −2.5 μM; Figure 1e), where the strength of the interaction is
reﬂected in the shape of the binding curve for which a steeper
gradient in the observed curve indicates tighter binding (compare
Table 1 Summary of the binding afﬁnities of Tah1, CHIP and cSti1
(a)
Tah1 interactions with... Kd (μM) Stoichiometry (N)
Yeast Hsp90 0.78+ −0.06 1.1
C-terminal domain of Hsp90 0.32+ −0.03 0.93
Hsp90α 0.33+ −0.03 1.1
Hsp90β 0.34+ −0.07 0.84
Ssa1 16+ −2.5 1.0 (ﬁxed)
Yeast Hsp90 peptides
MEEVD 35.4+ −4.4 1.1
TEMEEVD 0.95+ −0.04 1.2
PADTEMEEVD 0.73+ −0.04 1.0
PADAAMEEVD 0.75+ −0.04 0.81
PADTEAEEVD 3.3+ −0.2 0.89
PADTEVEEVD 9.8+ −0.7 1.1
Human Hsp90 peptides
DDTSRMEEVD 0.9+ −0.06 1.1
EDASRMEEVD 1.0+ −0.19 0.81
Ssa1 peptides
VEEVD 48.8+ −5.5 1.0 (ﬁxed)
PTVEEVD 10.6+ −1.4 1.0
AEGPTVEEVD 28.9+ −3.1 1.2
AEGPTAEEVD 14.8+ −0.7 1.1
AEGPTMEEVD 4.2+ −0.5 0.98
(b)
Hsp90 and M705V interactions Kd (μM) Stoichiometry (N)
CHIP–Hsp90 4.2+ −0.63 1.2
CHIP–Hsp90 M705V 6.7+ −0.62 1.1
cSti1–Hsp90 0.04+ −0.01 0.88
cSti1–Hsp90 M705V 0.2+ −0.03 0.98
Tah1–Hsp90 M705V 13+ −1.7 0.83
Figures 1a and 1e), and suggests that Tah1 is an Hsp90-speciﬁc
co-chaperone.
Comparison of MEEVD peptide binding to Tah1 and TPR2a
In the TPR1–VEEVD and TPR2a–MEEVD complexes most of
the direct hydrogen-bonded interactions with bound peptide
involve the main chain and are therefore sequence independent.
Both complexes have a highly conserved two-carboxylate clamp.
In the TPR2a complex the terminal main chain carboxylate
of MEEVD is hydrogen bonded to Lys
229,A s n
233 and Asn
264.
These residues are also conserved in Tah1 (Lys
8,A s n
12 and
Asn
43 respectively; see Supplementary Figure S1 and Figure 2).
However, in contrast, residues that interact with the side chain
of the terminal aspartate residue, which is bound by Lys
301 and
Gln
298 in TPR2a, are not conserved in Tah1 (Thr
70 and His
73
respectively). Consequently, if a two-carboxylate clamp exists in
the peptide-bound Tah1 complex it is clearly different to that seen
in TPR2a. Other electrostatic interactions include a tetrahedrally
co-ordinated water molecule that interacts with the carboxylate
side chain of the terminal aspartate residue, and with the main
chain carbonyl of Thr
263 (Ser
42 in Tah1), the guanidinium group
of Arg
305 (Arg
77 in Tah1) and the side chain carbonyl of Asn
264
(Asn
43 inTah1).ThesidechainamideofAsn
264 isalsoinvolvedin
main chain interactions with the backbone amide of the terminal
aspartate residue, whereas the guanidinium group of Arg
305 also
contactsthemainchaincarbonylandamide(viaawatermolecule)
of Glu
−2 (S
−6RMEEVD
0). Furthermore, the hydroxy group of
Tyr
236 (Phe
15 in Tah1; Supplementary Figure S1 and Figure 2)
contacts the main chain carbonyl of Glu
−3, an interaction not
possible with Phe
15 of Tah1, whereas the side chain carbonyl
group of Glu
271 (Lys
50 in Tah1) contacts the main chain amide
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Figure 2 Pymol diagram showing the interaction of the MEEVD peptide
with the TPR2a domain of Hop
Residues are labelled and those residues in brackets are the equivalent residues of Tah1. The
single letter amino acid code is used for the MEEVD peptide sequence. Water molecules are
shown as cyan coloured balls and polar interactions are shown as broken lines.
of Glu
−3. The only interactions to side chains (excluding the
two carboxylate clamp) are between the guanidinium group of
Arg
305 and the side chain amide of Asn
308 (Lys
79 in Tah1) to the
carboxylate group of Glu
−3. Additionally, Val
−1 is involved in a
hydrophobic interaction with a pocket formed by Asn
233,T y r
236
(Phe
15 inTah1),Asn
264 andAla
267 (Met
46 inTah1),whereastheside
chain of Met
−4 binds between Tyr
236 (Phe
15 in Tah1) and Glu
271
(Lys
50 in Tah1). Two further van der Waals contacts involve the
sidechainofGlu
−3 andAsp
−0 withPhe
270 (Ile
49 inTah1)andThr
260
(Val
39 in Tah1) respectively. It should be noted that the Glu
−2 side
chain is not involved in interactions. In summary, our alignments
suggest that there are signiﬁcant residue differences between
the TPR2a and the Tah1 TPR domain that point to differences
in the precise way that they would bind the MEEVD peptide
(Supplementary Figure S1 and Figure 2).
Ligand discrimination by Tah1 is similar to that of the TPR2a
domain of Hop
For Hop, the residue at position −4 of Hsp70 (I
−4EEVD
0 or
VEEVD for SsaI) and Hsp90 (MEEVD) primarily determines the
speciﬁcity for the TPR1 and TPR2a domains respectively [29].
To determine whether Tah1 ligand discrimination was similar to
that of TPR2a we investigated the ability of Tah1 to bind peptides
representingtheC-terminalendsofHsp90andSsa1.Theresultsin
Figure 3showthat the bindingafﬁnityfor theC-terminal peptides
ofyeastHsp90increaseswithincreasingpeptidelength(MEEVD,
Kd =35.4+ −4.4 μM; TEMEEVD, Kd =0.95+ −0.04 μM;
PADTEMEEVD, Kd =0.73+ −0.04 μM; Figures 3a–3c) and that
the decapeptide most probably represents the intact binding site
for Tah1 (PADTEMEEVD, Kd =0.73+ −0.04 μM and full-length
yeast Hsp90, Kd =0.78+ −0.06 μM; Figures 1a and 3c respect-
ively). Indeed, the binding of Tah1 to the human Hsp90α and
Hsp90β decapeptide was also similar to that of the corresponding
full-lengthproteins(Hsp90αdecapeptide,DDTSRMEEVD,Kd =
0.9+ −0.06 μM; Hsp90β decapeptide, EDASRMEEVD,
Kd =1.0+ −0.19 μM; full-length Hsp90α, Kd =0.33+ −0.03 μM
and full-length Hsp90β, Kd =0.34+ −0.07 μM; Figures 1c, 1d, 3d
Figure 3 ITC of Tah1 with Hsp90 peptides carrying the MEEVD motif
ITC by injecting into Tah1 (a) the pentapeptide MEEVD, (b) the heptapeptide TEMEEVD and
(c)thedecapeptidePADTEMEEVD(allrepresentingtheC-terminalendofyeastHsp90),andthe
decapeptides (d) DDTSRMEEVD and (e) EDASRMEEVD (representing the human Hsp90α and
Hsp90β C-terminal ends). The results show that the Tah1 interaction increases in afﬁnity with
increasing length of the peptide and that decapeptides representing the extreme C-terminus of
Hsp90α and Hsp90β bind with a similar afﬁnity to the equivalent decapeptide of yeast Hsp90.
and 3e). In contrast with the Hsp90 decapeptides, peptides repre-
senting the C-terminal end of Ssa1 showed a signiﬁcantly weaker
afﬁnity for Tah1 (VEEVD, Kd =48.8+ −5.5 μM; PTVEEVD,
Kd =10.6+ −1.4 μM; and AEGPTVEEVD, Kd =28.9+ −3.1 μM;
Figures 4a–4c).
The methione residue of the conserved MEEVD motif confers
tight Tah1 binding
The results so far show that Tah1 preferentially binds Hsp90 over
Ssa1. Consequently, we next investigated the mechanism behind
this selectivity. A comparison of the decapeptide sequences from
a variety of cytoplasmic Hsp90s suggests that there is very little
sequence conservation upstream of the conserved MEEVD motif,
e x c e p ta tt h e−6 position (91% conservation) and −5 position
(68% conservation) [29]. This suggests that position −6 (which
is mainly a serine residue and rarely a threonine residue) may
be critical for the speciﬁcity in the interaction with Tah1. Using
ITC, the binding of the PADAAMEEVD decapeptide (changes to
wild-type sequence are shown in italic; Kd =0.75+ −0.04 μM;
Figure 5a) was found to be similar to the decapeptide with
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Figure 4 ITC of Tah1 and Ssa1 peptides containing the VEEVD motif
ITC by injecting into Tah1 (a) the pentapeptide VEEVD, (b) the heptapeptide PTVEEVD and
(c) the decapeptide AEGEPTVEED, representing the extreme C-terminus of Ssa1. The results
showthattheTah1interactionwithSsa1peptidesremainsweakanddoesnotincreaseinafﬁnity
with increasing peptide length, in contrast with equivalent peptides based on Hsp90.
wild-type sequence (PADTEMEEVD, Kd =0.73+ −0.04 μM;
Figure 3c). Consequently, tight binding of Tah1 to Hsp90 is
determined within the conserved MEEVD motif, and upstream
amino acids appear to be involved in mainly main chain interac-
tions. However, since the EEVD motif is common to both Ssa1
and Hsp90 it follows that the conserved methionine residue of the
MEEVD motif is responsible for affecting tight binding to Tah1.
Theresultsofthepresentstudyshowthatadecapeptidecontaining
an alanine (PADTEAEEVD) or valine (PADTEVEEVD) residue
inplaceoftheconservedmethionineresidueintheMEEVDmotif
signiﬁcantly reduced the afﬁnity for Tah1 (Kd =3.3+ −0.2 and
9.8+ −0.7 μMrespectively;Figures5band5c)relativetothewild-
type decapeptide (Kd =0.73+ −0.04 μM; Figure 3c). Therefore
the results suggest that ligand discrimination for the MEEVD
peptide by Tah1 and the TPR2a domain of Hop [21] is similar
in that both favour a methionine residue at position −4o ft h e
MEEVD motif of Hsp90.
Tah1 positively discriminates against the valine residue at position
−4 in the AEGPTVEEVD motif of Ssa1
The results so far suggest that the ﬁrst valine residue in the
VEEVD motif of Ssa1 prevents tight association with Tah1. Thus
introducing an alanine or methionine residue at position −4o f
the Ssa1 decapeptide should increase the binding afﬁnity relative
to a decapeptide containing a valine residue at this position. Our
results show that this is indeed the case, where the decapeptides
AEGPTAEEVD and AEGPTMEEVD were found to bind with
increasing afﬁnity (Kd =14.8+ −0.7 μMa n dKd =4.2+ −0.5 μM
respectively;Figures5dand5e)relativetothewild-typesequence
decapeptide (Kd =28.9+ −3.1 μM; Figure 4c).
The M705V mutation of Hsp90 disrupts Tah1 binding
Having established with decapeptides that the methionine residue
in the conserved MEEVD motif of Hsp90 confers speciﬁcity for
Tah1 binding we investigated whether this was also true for the
Figure 5 ITC with Tah1 and peptides with altered Hsp90 and Ssa1
sequences
ITC by injecting into Tah1 the modiﬁed decapeptides (a)P A D AAMEEVD, (b) PADTEAEEVD,
(c)PADAAVEEVD,(d)AEGPTAEEVDand(e)AEGPTMEEVD.Theresultsshowthattheupstream
conserved TE motif (in PADTEMEEVD) of Hsp90 when replaced by Ala–Ala does not disrupt
binding to Tah1, and that at position −4 a methionine residue is favoured over an alanine or
valineresidue.Theresultsalsoshowthatamethionineresidue,andtoalesserextentanalanine
residue, at position −4 of the Ssa1 decapeptide increases the binding afﬁnity of the peptide
over that containing a valine resdiue at this position.
intact yeast Hsp90. We therefore made the yeast Hsp90 M705V
mutation to see whether it would bind Tah1 signiﬁcantly less
tightly. First we tested the M705V mutation with CHIP, known
to bind both Hsp90 and Hsp70, and then with the C-terminal
domain of Sti1 (cSti1), which favours Hsp90 binding. As
expected, the M705V mutation bound CHIP with more or
less equal afﬁnity (Kd =6.7+ −0.62 μM) relative to wild-type
Hsp90 (Kd =4.2+ −0.63 μM; Figures 6a and 6b). A previous
estimate for the CHIP and human Hsp90β interaction by ITC
(Kd =4.9 μM) is consistent with the value obtained in the present
study with yeast protein [24]. For cSti1, the M705V mutation
bound less tightly (Kd =0.20+ −0.03 μM) than the wild-type
protein (Kd =0.04+ −0.01 μM; Figures 6c and 6d). It is noted that
previousestimateswithfull-lengthSti1appeartobeslightlylower
in afﬁnity (Kd =0.24+ −0.07 μM and 0.33+ −0.03 μM; [35,47])
against the wild-type Hsp90, indicating that TPR1 may have a
negative effect on the binding of the TPR2a domain. However,
having established that the M705V mutation affected the binding
ofbothCHIPandthecSti1inapredictablemanner,wenexttested
the binding of Tah1 and, as expected, we found that the M705V
mutation inhibited the binding of Tah1 (Kd =13+ −1.7 μM) relat-
ive to wild-type protein (Kd =0.78+ −0.06 μM; Figures 1a and
6e).
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Figure 6 ITC of TPR-domain-containing proteins and the Hsp90 M705V
mutation
ITC by injecting CHIP into (a) yeast Hsp90 (yHsp90) or (b) M705V mutant, or by injecting
(c)yeastHsp90or(d)M705VmutantintocSti1,orbyinjecting(e)Tah1intotheM705Vmutant.
The results show that the M705V mutation of Hsp90 does not affect the binding of CHIP, but, in
contrast, the binding of the cSti1 and Tah1 is signiﬁcantly weaker.
Tah1 weakly stimulates the ATPase activity of Hsp90
TPR-domain-containing proteins have been implicated in the
regulation of the ATPase activity of Hsp90. The ﬁrst report of
such regulation was for Sti1, which was shown to be a potent
inhibitor of the ATPase activity of Hsp90 [35]. In contrast,
the TPR-domain-containing co-chaperone, Cpr6 (cyclosporin-
sensitive proline rotamase 6), has been shown to have a weak
stimulatory affect on the ATPase activity of Hsp90 [45]. Using
a 10-fold excess of Tah1 we were able to show in the present
study a very weak stimulation of the ATPase activity of Hsp90
(Figure 7a).
Tah1 appears to be primarily monomeric
TPR-domain-containing proteins have been shown to be both
monomeric [immunophillins such as, FKBP51 (FK506-binding
protein 51) and Cpr6] and dimeric (Hop/Sti1 and CHIP) in nature
[24,35,48].Wewereinterestedindeterminingtheoligomericstate
ofTah1.Weemployedgel-ﬁltrationchromatographytodetermine
therelativemolecularmassofTah1.Tah1eluted,asasinglepeak,
withaMr of18500(Figure7b).AsTah1isbasicallyaTPRdomain
it is reasonable to expect this protein to be slightly elongated,
rather than globular, in common with other TPR-domain motifs.
Consequently, on gel ﬁltration it would appear slightly larger
Figure 7 Tah1 activation of Hsp90 and determination of the relative
molecular mass of Tah1
(a) ATPase activation of yeast Hsp90 by PreScission-cleaved Tah1; (b) gel-ﬁltration
chromatography of PreScission-cleaved Tah1; (c and d) analytical equilibrium sedimentation
ultracentrifugation analyses (INVEQ, Mﬁt and NONLIN ﬁts, top to bottom panels) of
PreScission-cleavedTah1at7.0mg·ml−1 (c)and(d)0.5mg·ml−1.Thebrokenlinerepresents
the ﬁt to the data points. The results show that PreScission-cleaved Tah1 can weakly activate
the ATPase activity of Hsp90, elutes with a Mr of 18500 on gel ﬁltration, which is close to the
values estimated by analytical centrifugation [M(z) by Mﬁt=15968 and 16106]. The results
indicate that Tah1 is mostly a monomer under the conditions used.
Table 2 Summary of values for parameters estimated via sedimentation
equilibrium analysis for Tah1 at two cell loading concentrations
Protein
concentration Kd by M(z) by M(z) by Kd  by
(mg·ml−1) INVEQ (mM) Mﬁt NONLIN  (kDa) NONLIN  (mM)
7.0 3.9 15.968 16.062 1.80
0.5 0.51 16.106 15.845 0.15
than Mr 12800 (cleaved Tah1). Our gel-ﬁltration results therefore
suggest that Tah1 is most probably monomeric. To support this
weconductedananalyticalsedimentationequilibriumanalysison
Tah1. Good results with high-quality ﬁts were obtained from both
7 and 0.5 mg·ml
−1 samples, and these are shown in Figures 7(c)
and 7(d). The Tah1 sample clearly cannot be simply monomeric,
as the average molecular mass (see Table 2) by two independent
methodsconﬁrmsthis.TheexcellentﬁtobtainedwiththeINVEQ
approach is essentially conclusive evidence that a dimeric species
is present (estimated to be approx. 19%), but probably not higher
oligomers, at least in signiﬁcant quantity. However, the single
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experimentat7 mg·ml
−1 isnotbyitselfcapableofdistinguishing
between the presence of a dimer in reversible equilibrium with
monomer, and an irreversible dimer being present. To make
this distinction we must compare the two, in this case widely
separated, solute concentrations. The predictions for the effect of
dilution are that, if a reversible dimer is present, the Kd value
estimated will be the same, but the average molecular mass will
decrease markedly. However, if an irreversible dimer is present,
the Kd value estimated will increase markedly, but the average
molecular mass will remain the same. Results shown in Table 2
indicate immediately that it is the second hypothesis that is
supported.
The results of the present study show that Tah1 is primarily
monomeric under the conditions used, but that some dimeric
species is also present. The fact that the monomeric form is not
in equilibrium with the dimeric species suggests that the dimer
may not be a biologically native species, but rather aggregated
molecules of Tah1.TPR domains are known to self-associate [20]
and we have in the present study observed irreversible aggre-
gation and precipitation of Tah1 on prolonged storage and during
handling of the protein. Even though our samples were spun
to remove such aggregates small soluble species might not be
removed by centrifugation. We therefore conclude that Tah1 is
mostprobablymonomericasabiologicallyactivespeciesandthat
the dimeric species is most probably an irreversibly aggregated
dimer.
DISCUSSION
The present study has shown that the TPR domain of Tah1 is
similar to that of the TPR2b domain of Hop. Tah1 was shown
to selectively favour the binding of a methionine residue over
a valine residue at position −4, and therefore selectively binds
Hsp90 over Ssa1, in common with the TPR2a domain of Hop.
However, although tight binding of ligand by Tah1 and the
TPR2a domain of Hop is dependent on a methionine residue at
this position, the overall interactions that these domains make
with the MEEVD motif are actually different since the sequence
conservation between the two domains is signiﬁcantly diverged.
This is even more remarkable as many of the upstream contacts
from the MEEVD motif and contacts made by the TPR2a domain
with MEEVD appear to be main chain contacts to their respective
peptides.
The orientation of peptide binding in different TPR domains
has been shown to vary. For example the peptide in the TPR2a–
MEEVD complex is bound in an antiparallel orientation to
α-helices 1, 3, 5 and 7 of the domain. However, in the Cyp40 and
FKBP51complexestheEEVDisboundintheoppositeorientation
[21–23,25]. Our amino-acid-sequence alignment showed that
for residues involved in contacting the MEEVD motif by the
TPR2a domain, seven residues are identical and eight residues
are different at equivalent positions in the Tah1 domain. Conse-
quently, the orientation in which the MEEVD peptide binds to
Tah1 cannot be assumed to be the same as seen in the TPR2a–
MEEVD complex, and must await structural determination to be
resolved.
Ahigh-afﬁnity-bindingmotiffortheTPR2bdomainofHophas
not been identiﬁed [21,29], but surprisingly Tah1 was shown to
be most similar to the TPR2b domain of Hop. This suggests that
differences between these two TPR domains direct their selectiv-
ity towards different binding sites. It is interesting to note that the
TPR2b domain has been shown to be critical for the interaction
of the TPR2a domain of yeast Sti1 with Hsp90 [49].
IthasalsobeenreportedthatbindingofTPRdomaincontaining
co-chaperones to Hsp70 and Hsp90 can inﬂuence the ATPase
activity of the chaperone [32–36]. Under the assay conditions
that we applied in the present study we were able to detect a
weak stimulation of the ATPase activity of Hsp90 with a 10-fold
excess of Tah1. Although this activation is very weak, the
ATPase activity of Hsp90 is critical to its proper functioning [46].
However, how TPR domain proteins bind the extreme C-terminus
of Hsp90 and inﬂuence its ATPase activity is still not understood
and may have to wait for structural studies to shed light on the
precise mechanism.
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